BioMaxima Fair Value
94
The fair market value of 944.F stock is 0.48 EUR. Relative to the market price of 2.71 EUR BioMaxima is overvalued by 82.3%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
BioMaxima Valuation
Current 944.F share ticker price is 2.71 EUR.
The fair value level of 0.48 EUR can be considered as an effective entry point for long-term investors to start investing in 944.F stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 82% higher its fair value
Current price is 94% higher its minimum value
Current price is 31% higher its maximum value
Market price:
944.F stock is greatly overvalued
It means the current price may concern as a High Risk Entry Point
BioMaxima SA Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
44.15
2
Median P/E over 5 years
11.29
3
Minimum P/E over 5 years
3.53
4
Earning per share (last 12 months)
0.18 PLN
Maximum value
1
x
4
=
1.88 EUR
Fair value
2
x
4
=
0.48 EUR
Minimum value
3
x
4
=
0.15 EUR
BioMaxima SA price metrics
31.2
Annual return (geometric mean)
79.2
Risk (standard deviation) of returns
β
-0.3
Beta (volatility compared to market)